🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7635683

Quinoxalinyl tripeptide hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7635476

Anti-hepatitis a virus antibodies

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7635688

Development of a preventive vaccine for filovirus infection in primates

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7632508

Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines

The United States of America · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7632510

Methods of inducing flavivirus immune responses through the administration of recombinant

The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7625871

Indole antiviral compositions and methods

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622113

Monoclonal antibodies that bind or neutralize dengue virus

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622123

Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7618623

Hybrid adeno-retroviral vector for the transfection of cells

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7611704

Compositions and methods for treating viral infections using antibodies and immunoconjugat

The Board of Regents of the University of Texas System · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7612093

Compositions of treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imi

United Therapeutics Corporation · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7608449

Methods and compositions related to high-titer pseudotyped retroviruses

The Regents of the University of California · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7608422

Simian immunodeficiency virus (SIV) molecular clone encoding mutant gag gene lacking inhib

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7608257

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

ONCOLYTICS BIOTECH INC. · Granted Tue Oct 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7605126

Acylaminoheteroaryl hepatitis C virus protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7601490

Development of influenza A antivirals

The Board of Regents of the University of Texas System · Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7601735

Antiviral compounds

Airgain, Inc. · Granted Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7592322

RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7589075

Use of an adenosine A3 receptor agonist for inhibition of viral replication

CAN-FITE BIOPHARMA LTD. · Granted Tue Sep 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7585667

Negative strand RNA virus replicon

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7582289

Viruses for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572828

Identification of anti-HIV compounds inhibiting virus assembly and binding of nucleocapsid

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7569340

Nanoarrays of single virus particles, methods and instrumentation for the fabrication and

Northwestern University · Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7566451

Human immunodeficiency virus-neutralizing human antibodies with improved breadth and poten

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted